Overexpression of MYC binding protein promotes invasion and migration in gastric cancer

  • Authors:
    • Lijie Gong
    • Yingjie Xia
    • Zhenyuan Qian
    • Ji Shi
    • Jungang Luo
    • Guangyuan Song
    • Ji Xu
    • Zaiyuan Ye
  • View Affiliations

  • Published online on: February 2, 2018     https://doi.org/10.3892/ol.2018.7944
  • Pages: 5243-5249
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer (GC) is the second leading cause of cancer‑associated mortality worldwide. Although the mortality rate of patients with GC has improved, it remains a significant health issue. The MYC proto‑oncogene protein serves key roles in cellular proliferation, differentiation, transformation and apoptosis. Previous studies have identified the abnormal expression of MYC‑binding protein (MYCBP) during tumorigenesis in multiple types of cancer. Furthermore, evidence demonstrates that the abnormal expression of MYCBP contributes to the invasion and migration of human cancer types, including colon cancer and glioma; however, its influence on GC remains unclear. In the present study, the expression of MYCBP in GC cells and tissues was analyzed by reverse transcription‑quantitative polymerase chain reaction. Additionally, GC cell lines were transfected with small interfering RNAs against MYCBP or lymphoid enhancer‑binding factor 1 (LEF‑1) and assessed by in vitro transwell migration and invasion assays. The results indicated that the expression of MYCBP in GC cells and tissues was markedly increased compared with a normal gastric epithelial cell line and adjacent normal gastric mucosal tissues, respectively. Furthermore, MYCBP downregulation notably inhibited the metastatic capacity of GC cells, and LEF‑1 knockdown was found to downregulate the expression of MYCBP. On the basis of the findings of the present study, MYCBP may be a direct target of the β‑catenin/LEF‑1 pathway via binding LEF‑1, and could potentially be used as a biomarker for the diagnosis and prognosis of GC.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gong L, Xia Y, Qian Z, Shi J, Luo J, Song G, Xu J and Ye Z: Overexpression of MYC binding protein promotes invasion and migration in gastric cancer. Oncol Lett 15: 5243-5249, 2018.
APA
Gong, L., Xia, Y., Qian, Z., Shi, J., Luo, J., Song, G. ... Ye, Z. (2018). Overexpression of MYC binding protein promotes invasion and migration in gastric cancer. Oncology Letters, 15, 5243-5249. https://doi.org/10.3892/ol.2018.7944
MLA
Gong, L., Xia, Y., Qian, Z., Shi, J., Luo, J., Song, G., Xu, J., Ye, Z."Overexpression of MYC binding protein promotes invasion and migration in gastric cancer". Oncology Letters 15.4 (2018): 5243-5249.
Chicago
Gong, L., Xia, Y., Qian, Z., Shi, J., Luo, J., Song, G., Xu, J., Ye, Z."Overexpression of MYC binding protein promotes invasion and migration in gastric cancer". Oncology Letters 15, no. 4 (2018): 5243-5249. https://doi.org/10.3892/ol.2018.7944